Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Charles M. Gieseker is active.

Publication


Featured researches published by Charles M. Gieseker.


Journal of Agricultural and Food Chemistry | 2008

Determination and Confirmation of Melamine Residues in Catfish, Trout, Tilapia, Salmon, and Shrimp by Liquid Chromatography with Tandem Mass Spectrometry

Wendy C. Andersen; Sherri B. Turnipseed; Susan B. Clark; Mark R. Madson; Charles M. Gieseker; Ron A. Miller; Nathan Rummel; Renate Reimschuessel

Pet and food animal (hogs, chicken, and fish) feeds were recently found to be contaminated with melamine (MEL). A quantitative and confirmatory method is presented to determine MEL residues in edible tissues from fish fed this contaminant. Edible tissues were extracted with acidic acetonitrile, defatted with dichloromethane, and cleaned up using mixed-mode cation exchange solid-phase extraction cartridges. Extracts were analyzed by liquid chromatography with tandem mass spectrometry with hydrophilic interaction chromatography and electrospray ionization in positive ion mode. Fish and shrimp tissues were fortified with 10-500 microg/kg (ppb) of MEL with an average recovery of 63.8% (21.5% relative standard deviation, n = 121). Incurred fish tissues were generated by feeding fish up to 400 mg/kg of MEL or a combination of MEL and the related triazine cyanuric acid (CYA). MEL and CYA are known to form an insoluble complex in the kidneys, which may lead to renal failure. Fifty-five treated catfish, trout, tilapia, and salmon were analyzed after withdrawal times of 1-14 days. MEL residues were found in edible tissues from all of the fish with concentrations ranging from 0.011 to 210 mg/kg (ppm). Incurred shrimp and a survey of market seafood products were also analyzed as part of this study.


American Journal of Veterinary Research | 2008

Evaluation of the renal effects of experimental feeding of melamine and cyanuric acid to fish and pigs.

Renate Reimschuessel; Charles M. Gieseker; Ron A. Miller; Jeffrey L. Ward; Jamie L. Boehmer; Nathan Rummel; David N. Heller; Cristina B. Nochetto; G. K. Hemakanthi de Alwis; Neal Bataller; Wendy C. Andersen; Sherri B. Turnipseed; R. Duane Satzger; John B. Crowe; Nancy R. Wilber; Mary K. Reinhard; John F. Roberts; Mark R. Witkowski

OBJECTIVEnTo determine whether renal crystals can be experimentally induced in animals fed melamine or the related triazine compound cyanuric acid, separately or in combination, and to compare experimentally induced crystals with those from a cat with triazine-related renal failure.nnnANIMALSn75 fish (21 tilapia, 24 rainbow trout, 15 channel catfish, and 15 Atlantic salmon), 4 pigs, and 1 cat that was euthanatized because of renal failure.nnnPROCEDURESnFish and pigs were fed a target dosage of melamine (400 mg/kg), cyanuric acid (400 mg/kg), or melamine and cyanuric acid (400 mg of each compound/kg) daily for 3 days and were euthanatized 1, 3, 6, 10, or 14 days after administration ceased. Fresh, frozen, and formalin-fixed kidneys were examined for crystals. Edible tissues were collected for residue analysis. Crystals were examined for composition via Raman spectroscopy and hydrophilic-interaction liquid chromatography-tandem mass spectrometry.nnnRESULTSnAll animals fed the combination of melamine and cyanuric acid developed goldbrown renal crystals arranged in radial spheres (spherulites), similar to those detected in the cat. Spectral analyses of crystals from the cat, pigs, and fish were consistent with melamine-cyanurate complex crystals. Melamine and cyanuric acid residues were identified in edible tissues of fish.nnnCONCLUSIONS AND CLINICAL RELEVANCEnAlthough melamine and cyanuric acid appeared to have low toxicity when administered separately, they induced extensive renal crystal formation when administered together. The subsequent renal failure may be similar to acute uric acid nephropathy in humans, in which crystal spherulites obstruct renal tubules.


Food and Chemical Toxicology | 2010

Renal crystal formation after combined or sequential oral administration of melamine and cyanuric acid

Renate Reimschuessel; Eric Evans; Cynthia B. Stine; N. Hasbrouck; T. D. Mayer; C. Nochetto; Charles M. Gieseker

We evaluated renal melamine-cyanurate crystal spherulite formation after single and repeated ingestion of both melamine (MEL) and cyanuric acid (CYA) in catfish and trout. MEL and CYA were co-administered orally over a range of doses, 0.1-20mg/kg body weight (bw) of each compound, either once or repeatedly for 4, 14 or 28 days (d). In catfish, the No Observable Adverse Effects Levels (NOAELs) for crystal formation for single, 4d or 14 d dosing were 10, 2.5 and 0.5mg/kg bw, respectively. In trout, the respective NOAELs were 2.5, 2.5 and 0.5mg/kg bw. No renal crystals formed in catfish fed 0.1mg/kg bw of each compound for 28 d. Sequential administration of 20mg/kg bw of MEL followed by 20mg/kg bw of CYA or vise-versa, with waiting periods of 1, 3, 7, 14 or 21 d between compound dosing also induced renal crystal formation in fish. These studies show that both catfish and trout are sensitive, non-mammalian models, for renal crystal formation following MEL and CYA ingestion. Since fish generally excrete chemicals more slowly than mammals, they may provide a worst case scenario model for higher risk populations, such as infants or persons with compromised renal function.


Journal of Veterinary Pharmacology and Therapeutics | 2010

Residue depletion of melamine and cyanuric acid in catfish and rainbow trout following oral administration

Renate Reimschuessel; Eric Evans; Wendy C. Andersen; Sherri B. Turnipseed; T. D. Mayer; C. Nochetto; Nathan Rummel; Charles M. Gieseker

The intentional addition of triazines such as melamine to animal feeds and the lack of information about residue accumulation in food animals caused global concerns for food safety during 2007 and 2008. We report the results of a good laboratory practices (GLP) study to determine melamine and cyanuric acid residues in catfish and trout filets harvested at 1, 3, 7, 14, 28, and 42 days after a single oral dose of 20 mg/kg body weight of melamine, cyanuric acid, or melamine and cyanuric acid together. Peak melamine concentrations were 12.73 mg/kg (ppm) in catfish (mean = 9.98), 12.26 mg/kg in trout (mean = 7.89) on day 1. Within 7 days (catfish) or 14 days (trout) residues were <2.5 mg/kg, a level in foods accepted by many risk assessors worldwide to be unlikely to pose health risks to consumers. Peak cyanuric acid residues also occurred on day 1, 0.68 mg/kg in catfish (mean = 0.46), 2.59 mg/kg in trout (mean = 0.86). Cyanuric acid muscle residues were <2.5 mg/kg by day 3. The half-lives for melamine and cyanuric acid ranged between 1 and 4 days. Renal crystals formed in fish given both melamine and cyanuric acid, persisting for weeks after the single dose.


Journal of Chromatography A | 2009

Simultaneous screening and confirmation of multiple classes of drug residues in fish by liquid chromatography-ion trap mass spectrometry

Shani Smith; Charles M. Gieseker; Renate Reimschuessel; Christie-Sue Decker; Mary C. Carson

LC-ion trap mass spectrometry was used to screen and confirm 38 compounds from a variety of drug classes in four species of fish: trout, salmon, catfish, and tilapia. Samples were extracted with acetonitrile and hexane. The acetonitrile phase was evaporated, redissolved in water and acetonitrile, and analyzed by gradient chromatography on a phenyl column. MS(2) or MS(3) spectra were monitored for each compound. Qualitative method performance was evaluated by the analysis over several days of replicate samples of control fish, fish fortified with a drug mixture at 1 ppm, 0.1 ppm and 0.01 ppm, and fish dosed with a representative from each drug class. Half of the 38 drugs were confirmed at 0.01 ppm, the lowest fortification level. This included all of the quinolones and fluoroquinolones, the macrolides, malachite green, and most of the imidazoles. Florfenicol amine, metronidazole, sulfonamides, tetracyclines, and most of the betalactams were confirmed at 0.1 ppm. Ivermectin and penicillin G were only detectable in the 1 ppm fortified samples. With the exception of amoxicillin, emamectin, metronidazole, and tylosin, residue presence was confirmed in all the dosed fish.


Diseases of Aquatic Organisms | 2012

Quality control ranges for testing broth microdilution susceptibility of Flavobacterium columnare and F. psychrophilum to nine antimicrobials

Charles M. Gieseker; Tamara D. Mayer; Tina C. Crosby; J Carson; Inger Dalsgaard; Ahmed M. Darwish; Patricia S. Gaunt; Dana X. Gao; Hui-Min Hsu; Tsang L. Lin; J. Lindsay Oaks; Melissa Pyecroft; Charlene Teitzel; Temdoung Somsiri; Ching C. Wu

A multi-laboratory broth microdilution method trial was performed to standardize the specialized test conditions required for the fish pathogens Flavobacterium columnare and F. psychrophilum. Nine laboratories tested the quality control (QC) strains Escherichia coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658 against 10 antimicrobials (ampicillin, enrofloxacin, erythromycin, florfenicol, flumequine, gentamicin, ormetoprim/sulfadimethoxine, oxolinic acid, oxytetracycline, and trimethoprim/sulfamethoxazole) in diluted (4 g l-1) cation-adjusted Mueller-Hinton broth incubated at 28 and 18°C for 44-48 and 92-96 h, respectively. QC ranges were set for 9 of the 10 antimicrobials. Most of the minimal inhibitory concentration (MIC) distributions (16 of 18, 9 drugs at both temperatures) for A. salmonicida ATCC 33658 were centered on a single median MIC ± 1 two-fold drug dilution resulting in a QC range that spanned 3 dilutions. More of the E. coli ATCC 25922 MIC distributions (7 of 16) were centered between 2 MIC dilutions requiring a QC range that spanned 4 dilutions. A QC range could not be determined for E. coli ATCC 25922 against 2 antimicrobials at the low temperature. These data and their associated QC ranges have been approved by the Clinical and Laboratory Standards Institute (CLSI), and will be included in the next edition of the CLSI M49-A Guideline. This method represents the first standardized reference method for testing fish pathogenic Flavobacterium spp.


Diseases of Aquatic Organisms | 2011

In vitro effect of seven antiparasitics on Acolpenteron ureteroecetes (Dactylogyridae) from largemouth bass Micropterus salmoides (Centrarchidae)

Renate Reimschuessel; Charles M. Gieseker; Sarah L. Poynton

Few drugs are approved by the United States Food and Drug Administration for treating parasite infections in minor species such as fish, due in part to the high cost of developing such drugs and to a relatively small market share for drug sponsors. Because in vivo effectiveness trials for antiparasitic drugs are costly, time consuming, and use many animals, a systematic in vitro screening approach to describe parasite motility could help find promising drug candidates. We evaluated the effects of 7 antiparasitics on the activity and survival of the endoparasitic monogenean Acolpenteron ureteroecetes (Dactylogyridae) collected from the posterior kidneys of juvenile largemouth bass Micropterus salmoides (Lacepede, 1802) (Centrarchidae) held in the laboratory. Tests were conducted in 12 well tissue culture plates; each well had 3 parasites, and we tested 3 concentrations and 1 control for each of the 7 antiparasitics. The parasites were observed immediately after adding the drug, at 1 to 3 h, and 17 to 26 h, and video recordings were made. Drug effects were recorded by documenting morbidity (reduced movement, tremors, contracted body, abnormal morphology) and mortality. A. ureteroecetes was strongly affected by the quinoline praziquantel, the imidazothiazide levamisole, and the organophosphates dichlorvos and trichlorfon. The parasites were moderately affected by the macrocyclic lactones ivermectin and emamectin, and generally unaffected by the benzimidazole mebendazole. Our study demonstrates the utility of characterizing in vitro responses with video microscopy to document responses of fish parasites for initial screens of drug effects on a fish monogenean.


Journal of Agricultural and Food Chemistry | 2011

Bioaccumulation of melamine in catfish muscle following continuous, low-dose, oral administration.

Wendy C. Andersen; Sherri B. Turnipseed; Eric Evans; Nicholas R. Hasbrouck; Tamara D. Mayer; Charles M. Gieseker; Cristina B. Nochetto; Cynthia B. Stine; Renate Reimschuessel

In this study, catfish muscle was analyzed for melamine (MEL) and cyanuric acid (CYA) residues following experimental feeding with low doses of MEL and MEL and CYA (MEL+CYA) and with the insoluble melamine-cyanurate complex (MEL=CYA). Catfish were daily fed 0.1 mg/kg BW of MEL for 15, 28, or 42 days, 0.1 mg/kg BW of MEL+CYA for 28 days, 2.5 mg/kg BW of MEL+CYA for 14 days, or 400 mg/kg BW of MEL=CYA for 3 days. Residues in the tissue were determined by LC-MS/MS. MEL was extracted with acidic acetonitrile, followed by defatting with dichloromethane, and isolated with cation exchange solid phase extraction (SPE). For CYA analysis, fish were extracted with dilute acetic acid, defatted with hexane, and cleaned up with a graphitic carbon SPE. Catfish fed 0.1 mg/kg BW of MEL reached a maximum muscle residue concentration of 0.33 ± 0.04 mg/kg (ppm) after 28 days of continuous feeding. The same concentration was found for MEL+CYA feeding at the 0.1 mg/kg BW level for 28 days. Feeding at 2.5 mg/kg BW of MEL+CYA yielded muscle concentrations above the 2.5 mg/kg level of concern for most of the study fish. Finally, catfish fed high levels of the MEL=CYA complex (400 mg/kg BW) accumulated relatively little MEL in the muscle (0.14 ± 0.07 mg/kg) and, unlike treatment with MEL+CYA, did not form renal melamine-cyanurate crystals. Appreciable concentrations of CYA were not detected in any of the muscles tested. These studies provide data to model the bioaccumulation of triazine residues into edible fish tissue as a result of the continuous consumption of adulterated feed.


Journal of Aquatic Animal Health | 2016

Development of Similar Broth Microdilution Methods to Determine the Antimicrobial Susceptibility of Flavobacterium columnare and F. psychrophilum

Charles M. Gieseker; Tina C. Crosby; Tamara D. Mayer; Sonya M. Bodeis; Cynthia B. Stine

Flavobacterium columnare and F. psychrophilum are major fish pathogens that cause diseases that may require antimicrobial therapy. Choice of appropriate treatment is dependent upon determining the antimicrobial susceptibility of isolates. Therefore we optimized methods for broth microdilution testing of F. columnare and F. psychrophilum to facilitate standardizing an antimicrobial susceptibility test. We developed adaptations to make reproducible broth inoculums and confirmed the proper incubation time and media composition. We tested the stability of potential quality-control bacteria and compared test results between different operators. Log phase occurred at 48 h for F. columnare and 72-96 h for F. psychrophilum, confirming the test should be incubated at 28°C for approximately 48 h and at 18°C for approximately 96 h, respectively. The most consistent susceptibility results were achieved with plain, 4-g/L, dilute Mueller-Hinton broth supplemented with dilute calcium and magnesium. Supplementing the broth with horse serum did not improve growth. The quality-control strains, Escherichia coli ATCC 25922 and Aeromonas salmonicida subsp. salmonicida ATCC 33658, yielded stable minimal inhibitory concentrations (MIC) against all seven antimicrobials tested after 30 passes at 28°C and 15 passes at 18°C. In comparison tests, most MICs of the isolates agreed 100% within one drug dilution for ampicillin, florfenicol, and oxytetracycline. The agreement was lower with the ormetoprim-sulfdimethoxine combination, but there was at least 75% agreement for all but one isolate. These experiments have provided methods to help standardize antimicrobial susceptibility testing of these nutritionally fastidious aquatic bacteria. Received June 24, 2015; accepted October 2, 2015.


Journal of Aquatic Animal Health | 2007

Laboratory Transmission of the Monogenean Acolpenteron ureteroecetes Infecting the Posterior Kidneys of Largemouth Bass: Time Course and Pathology

Charles M. Gieseker; Stanley G. Serfling; Sarah L. Poynton; Renate Reimschuessel

Acolpenteron ureteroecetes infections in the kidneys of largemouth bass Micropterus salmoides have been reported, but the time course of infection and progression of pathology in experimentally infected fish remain unknown. We exposed 299 naive juvenile largemouth bass at 19.8 degrees C to A. ureteroecetes-infected largemouth bass via recirculating water without direct contact. For 7 months, prevalence and density were determined monthly in squashes of posterior kidney (20 exposed fish, 20 nonexposed fish), and histopathology was assessed in 5 fish from each group. Prevalence increased steadily from months 1 (5%) to 4 (85%), thereafter remaining relatively stable. Mean density of infection doubled monthly (month 1, 0.1 individuals/2 cm2 squash; month 7, 15.1 individuals/2 cm2 squash). Eggs were first observed at month 3, and mean density increased markedly from month 4 to month 5 (2.9-15.3 eggs/2 cm2 squash). Histopathology showed damage in renal collecting ducts that got progressively worse between 5 and 7 months. The infected ducts were dilated, had a hyperplastic epithelium, and were surrounded by chronic inflammation, including eosinophilic granular cells and varying degrees of fibrosis. Eggs within granulomas were present in the interstitium; this response is newly reported. The infection system developed in this study provides a reproducible and consistent source of infected individuals that will facilitate further study of the parasite and potential treatments.

Collaboration


Dive into the Charles M. Gieseker's collaboration.

Top Co-Authors

Avatar

Renate Reimschuessel

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Nathan Rummel

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Eric Evans

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Sherri B. Turnipseed

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Wendy C. Andersen

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Cynthia B. Stine

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

C. Nochetto

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Ron A. Miller

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

T. D. Mayer

Food and Drug Administration

View shared research outputs
Top Co-Authors

Avatar

Tina C. Crosby

Food and Drug Administration

View shared research outputs
Researchain Logo
Decentralizing Knowledge